700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02455

Synthetic patientMETA-24 · Day 176 · 25–34 · F · baseline S09Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
8%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S09
  2. Day 14 Trajectory diverged from prediction — Observed response fell below the model's expected path.
  3. Day 22 DT-01 recommended — Dosing / Timing Recommendation DT-01
  4. Day 23 Patient accepted — Started DT-01 in the companion
  5. Day 28 GI symptom burden −15% vs expected — Dosing / Timing Recommendation DT-01
  6. Day 34 Tolerance state changed — Unstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 14.

Primary contributors, last 14 days
  • GI instability-12
  • Nutritional resilience+9
  • Inflammatory activity-2
  • Toxicity+2

What helped?

  • Dosing / Timing Recommendation DT-01Day 22
    Result: symptom burden −15%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
52 min
improving · +9.1 vs previous 14 d
Sleep duration
Wearable
7.5 h
stable · +0.3 vs previous 14 d
Energy level
Daily log
6.3/10
improving · +0.8 vs previous 14 d
Steps
Wearable
5,378
improving · +889 vs previous 14 d
GI burden
Companion
13.7/100
improving · -10.2 vs previous 14 d
Adherence
Companion
93.8 %
stable · +1.3 vs previous 14 d
Sleep quality
Wearable
60.6/100
improving · +5.2 vs previous 14 d
Glucose, CGM daily mean
CGM
119 mg/dL
improving · -8.2 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 76 from the failing basin, 28 from restoration.

Good elements to keep
  • Protein (supports)
    perturbation · steering +11.2
  • Dosing / Timing Recommendation DT-01
    intervention · steering +10.1
  • Daily walks resumed
    perturbation · steering +3.3
  • Protein
    supporter · GI -5.7 next day
Main detractors to watch
  • Low butyrate capacity
    hidden · steering -17.5
  • Dietary fat load
    perturbation · steering -10.4
  • Simple carbohydrates
    perturbation · steering -9.6
  • Low microbial diversity
    hidden · steering -7.7
  • Dietary fat load
    detractor · GI +6.1 next day
  • Simple carbohydrates
    detractor · GI +5.8 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +6.1detractor · 95%
  • Simple carbohydrates
    +5.8detractor · 95%
  • Protein
    -5.7supporter · 95%
  • Ultra-processed food
    +2.3no signal · 51%
  • Caffeine
    +1.7no signal · 34%
  • Histamine load
    -1.3no signal · 26%
  • Alcohol
    +1.2no signal · 25%
  • Insoluble fibre
    +0.6no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production ↓60
    • MicrobiomeButyrate capacity 42/100
    • MicrobiomeF. prausnitzii depleted
  • Inflammatory signalling ↓35
    • MicrobiomeBacteroides fragilis expansion
    • WearableHRV 38 ms, trending down
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 1.9 · butyrate capacity 42/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
40 ms
Sleep
7.3 h
Steps
4,805
Resting HR
61 bpm
Daily log: GI score 14, nutritional resilience 69, adherence 94.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
PatientSimilarityBaselineInterventionOutcomeResponse today
P-0269836%S06ME-01improved71
P-0255335%S13——71
P-0255034%S01——70
P-0219234%S05——69
P-0221436%S08SC-12no change69
P-0235634%S08——69
P-0208334%S13——69
P-0229334%S15HY-01no change68
P-0209036%S04——68
P-0251837%S17DT-01improved68
P-0246333%S18——68
P-0260437%S03——67